Live Amazon Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Akoya Biosciences, Inc.

AKYA

About Akoya Biosciences, Inc.

Akoya Biosciences, Inc. develops spatial biology solutions that enable high-parameter, single-cell resolution analysis of tissue samples while preserving spatial context. Its core products include the PhenoCycler and PhenoImager platforms, offering integrated instruments, proprietary reagents, software, and services for discovery, translational, and clinical research. Serving biopharma, academic, and clinical markets globally, Akoya’s technology advances biomarker discovery and disease understanding, particularly in oncology and immunology, through comprehensive spatial phenotyping workflows.

This description was generated via AI from an annual report. Updated about 1 year ago.

Latest SEC Filings from Akoya Biosciences, Inc.